Supplemental material
Open access
2,911
Views
4
CrossRef citations to date
0
Altmetric
Coronavirus – Research Paper
Vaccine-Related adverse events following AZD1222 (ChAdOx1-nCoV-19) Covid-19 vaccine in solid malignancy patients receiving cancer treatment, as compared to age-matched healthy controls
Nussara Pakvisala Division of Medical Oncology, Department of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, Bangkok, ThailandView further author information
, Panot Sainamthipb Department of Pharmacology, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, Bangkok, ThailandView further author information
, Nattaya Teeyapuna Division of Medical Oncology, Department of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, Bangkok, ThailandView further author information
, Sutima Luangdilokc Department of Biochemistry, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, Bangkok, ThailandView further author information
, Nassamon Wanlapakornd Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, Bangkok, ThailandView further author information
, Ritthideach Yorsaengd Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, Bangkok, ThailandView further author information
, Yong Poovorawand Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, Bangkok, ThailandView further author information
, Piyapoom Pakvisale Department of Medicine, Police General Hospital, Bangkok, ThailandView further author information
, Thiti Susiriwatananonta Division of Medical Oncology, Department of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, Bangkok, ThailandView further author information
, Nicha Zungsontiporna Division of Medical Oncology, Department of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, Bangkok, ThailandView further author information
, Virote Sriuranponga Division of Medical Oncology, Department of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, Bangkok, ThailandView further author information
, Suebpong Tanasanvimona Division of Medical Oncology, Department of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, Bangkok, ThailandView further author information
& Passakorn Wanchaijiraboonf Phrapokklao Cancer Center of Excellence, Phrapokklao Clinical Research center, Phrapokklao Genomic Laboratories, Phrapokklao Hospital, Chantaburi, ThailandCorrespondence[email protected]
View further author information
show allView further author information
Article: 2094149
|
Received 10 May 2022, Accepted 22 Jun 2022, Published online: 01 Jul 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.